Celcuity Inc. (CELC) Stock Analysis & Investment Frameworks
Celcuity Inc. (CELC) stock analysis on Invetso. Review Celcuity Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Celcuity Inc. Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Celcuity Inc. Key Financial Metrics
- Market Cap: $3.27B
- Revenue: $N/A
- ROE: -1522.54%
- ROIC: -35.70%
- Dividend Yield: N/A
About Celcuity Inc.
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.